In adults with CKM syndrome, finerenone vs. placebo reduced sudden death at a median 2.9 y

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Endocrinology: [Formula: see text] Nephrology: [Formula: see text].